Tilray Inc (TLRY) - Total Assets
Based on the latest financial reports, Tilray Inc (TLRY) holds total assets worth CA$2.07 Billion CAD (≈ $1.50 Billion USD) as of February 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Tilray Inc - Total Assets Trend (2012–2025)
This chart illustrates how Tilray Inc's total assets have evolved over time, based on quarterly financial data. Also see market value of Tilray Inc for the company's overall valuation and market capitalisation.
Tilray Inc - Asset Composition Analysis
Current Asset Composition (May 2025)
Tilray Inc's total assets of CA$2.07 Billion consist of 33.2% current assets and 66.8% non-current assets. Review Tilray Inc (TLRY) total liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (CAD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$0.00 | 10.7% |
| Accounts Receivable | CA$121.49 Million | 5.9% |
| Inventory | CA$270.88 Million | 13.1% |
| Property, Plant & Equipment | CA$0.00 | 0.0% |
| Intangible Assets | CA$21.42 Million | 1.0% |
| Goodwill | CA$752.35 Million | 36.3% |
Asset Composition Trend (2012–2025)
This chart illustrates how Tilray Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See TLRY stock price and chart for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Tilray Inc's current assets represent 33.2% of total assets in 2025, a decrease from 100.0% in 2012.
- Cash Position: Cash and equivalents constituted 10.7% of total assets in 2025, up from 6.9% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 37.0% of total assets, an increase from 0.0% in 2012.
- Asset Diversification: The largest asset category is goodwill at 36.3% of total assets.
Tilray Inc Competitors by Total Assets
Key competitors of Tilray Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
|
Sweden | Skr81.26 Billion |
|
Yunnan Baiyao Group Co Ltd
SHE:000538
|
China | CN¥53.34 Billion |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
|
China | CN¥5.17 Billion |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
|
USA | $15.42 Trillion |
|
Harbin Gloria Pharmaceuticals
SHE:002437
|
China | CN¥3.14 Billion |
|
Jiuzhitang Co Ltd
SHE:000989
|
China | CN¥5.73 Billion |
|
Renhe Pharmacy Co Ltd
SHE:000650
|
China | CN¥7.93 Billion |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
|
China | CN¥6.74 Billion |
Tilray Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.79 | 2.62 | 2.20 |
| Quick Ratio | 1.66 | 1.61 | 1.56 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CA$461.22 Million | CA$424.12 Million | CA$482.37 Million |
Tilray Inc - Advanced Valuation Insights
This section examines the relationship between Tilray Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.43 |
| Latest Market Cap to Assets Ratio | 0.23 |
| Asset Growth Rate (YoY) | -50.9% |
| Total Assets | CA$2.07 Billion |
| Market Capitalization | $483.65 Million USD |
Valuation Analysis
Below Book Valuation: The market values Tilray Inc's assets below their book value (0.23x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Tilray Inc's assets decreased by 50.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Tilray Inc (2012–2025)
The table below shows the annual total assets of Tilray Inc from 2012 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-05-31 | CA$2.07 Billion ≈ $1.50 Billion |
-50.86% |
| 2024-05-31 | CA$4.22 Billion ≈ $3.05 Billion |
-1.99% |
| 2023-05-31 | CA$4.31 Billion ≈ $3.12 Billion |
-20.96% |
| 2022-05-31 | CA$5.45 Billion ≈ $3.94 Billion |
-9.55% |
| 2021-05-31 | CA$6.03 Billion ≈ $4.36 Billion |
+234.51% |
| 2020-05-31 | CA$1.80 Billion ≈ $1.30 Billion |
-0.19% |
| 2019-05-31 | CA$1.80 Billion ≈ $1.31 Billion |
+77.08% |
| 2018-05-31 | CA$1.02 Billion ≈ $737.20 Million |
+334.50% |
| 2017-05-31 | CA$234.54 Million ≈ $169.66 Million |
+743.18% |
| 2016-05-31 | CA$27.82 Million ≈ $20.12 Million |
+141.87% |
| 2015-05-31 | CA$11.50 Million ≈ $8.32 Million |
+3974.25% |
| 2014-05-31 | CA$282.27K ≈ $204.19K |
0.00% |
| 2013-05-31 | CA$282.27K ≈ $204.19K |
-18.00% |
| 2012-05-31 | CA$344.23K ≈ $249.01K |
-- |
About Tilray Inc
Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and… Read more